Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
2021 · Journal of the National Comprehensive Cancer Network · 1,198 citations
https://doi.org/10.6004/jnccn.2021.0017
R
Robert A. Wolff
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.0K
Papers
46.0K
Citations
106
h-index
339
i10-index
Robert A. Wolff is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Genomics and Diagnostics & Colorectal Cancer Treatments and Studies. The author has an h-index of 106, co-authored 882 publications.
ORCID: 0000-0002-6614-1610Papers by this author
worksGemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
2019 · JAMA Oncology · 460 citations
https://doi.org/10.1001/jamaoncol.2019.0270
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
2022 · Nature Medicine · 325 citations
https://doi.org/10.1038/s41591-022-01829-9
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma
2011 · Cancer · 252 citations
https://doi.org/10.1002/cncr.26651
HER2/neu-directed therapy for biliary tract cancer
2015 · Journal of Hematology & Oncology · 220 citations
https://doi.org/10.1186/s13045-015-0155-z
Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i>
2004 · Cancer Investigation · 190 citations
https://doi.org/10.1081/cnv-200032974
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat